New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 1, 2013
16:05 EDTPDLIPDL BioPharma reports Q4 EPS 34c, consensus 32c
Reports Q4 revenue $86.0M, consensus $86.08M.
News For PDLI From The Last 14 Days
Check below for free stories on PDLI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
18:02 EDTPDLIPDL BioPharma issues statement on resignation of corporate auditors
PDL BioPharma was orally notified by its independent registered accounting firm, Ernst & Young, or EY, that it was resigning effective September 11. The resignation was confirmed in a letter delivered to the company on September 15, and reported in PDL's Form 8-K filed on September 16. PDL has issued the following statement in response to the announcement: "We have received a number of inquiries on the reason for the resignation of EY. We were surprised by the resignation as we did not have any disagreements with EY on accounting practices, scope or procedures nor did we have any reportable events that would have caused EY to resign their position as our auditors," stated Peter Garcia, VP and CFO of PDL. "We thank EY for their years of service to the company and have already begun the process of appointing new auditors, which we expect to announce in the coming weeks. We currently expect to continue our financial reporting in a timely manner." PDL BioPharma dropped 12% today following the revelation of Ernst & Young's resignation as corporate auditors.
10:48 EDTPDLIHigh option volume stocks
Subscribe for More Information
September 9, 2014
18:31 EDTPDLIOn The Fly: After Hours Movers
Subscribe for More Information
16:04 EDTPDLIPDL BioPharma sees Q3 revenue $165M, consensus $149.25M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use